Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hauser

Showing results (81-90 of 266) with videos related to

Pageof 27
Sort By:
Current Treatment Options in Neurology|October 3, 2001
Diffuse Lewy Body DiseaseTheresa A. Zesiewicz, Matthew J. Baker, Peter B. Dunne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2009
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's diseaseRobert A Hauser, Kelly E Lyons, Terry McClain, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2007
Tiagabine and exacerbation of essential tremorTheresa A Zesiewicz, Kelly L Sullivan, Christopher L Ward, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 31, 2006
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's diseaseTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser, et al.
Parkinsonism & Related Disorders|December 26, 2006
Prevalence and treatment of non-motor symptoms in Parkinson's diseaseKelly L Sullivan, Christopher L Ward, Robert A Hauser, et al.
Journal of Neurology|February 26, 2016
A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystoniaYi Han, Andrea L Stevens, Khashayar Dashtipour, et al.
Journal of the Neurological Sciences|February 14, 2018
The nosology of tardive syndromesKaren Frei, Daniel D Truong, Stanley Fahn, et al.
Neuropsychiatric Disease and Treatment|April 3, 2018
Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's diseaseRobert A Hauser, Aaron Ellenbogen, Sarita Khanna, et al.
Frontiers in Neurology|April 12, 2021
Amantadine ER (Gocovri<sup>®</sup>) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseRobert A Hauser, Ryan R Walsh, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)Robert A Hauser, Stuart Isaacson, Jerome P Lisk, et al.
Pageof 27

Showing results (81-90 of 266) with videos related to

Sort By:
Pageof 27
Current Treatment Options in Neurology|October 3, 2001
Diffuse Lewy Body DiseaseTheresa A. Zesiewicz, Matthew J. Baker, Peter B. Dunne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 21, 2009
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's diseaseRobert A Hauser, Kelly E Lyons, Terry McClain, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2007
Tiagabine and exacerbation of essential tremorTheresa A Zesiewicz, Kelly L Sullivan, Christopher L Ward, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 31, 2006
Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's diseaseTheresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser, et al.
Parkinsonism & Related Disorders|December 26, 2006
Prevalence and treatment of non-motor symptoms in Parkinson's diseaseKelly L Sullivan, Christopher L Ward, Robert A Hauser, et al.
Journal of Neurology|February 26, 2016
A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystoniaYi Han, Andrea L Stevens, Khashayar Dashtipour, et al.
Journal of the Neurological Sciences|February 14, 2018
The nosology of tardive syndromesKaren Frei, Daniel D Truong, Stanley Fahn, et al.
Neuropsychiatric Disease and Treatment|April 3, 2018
Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's diseaseRobert A Hauser, Aaron Ellenbogen, Sarita Khanna, et al.
Frontiers in Neurology|April 12, 2021
Amantadine ER (Gocovri<sup>®</sup>) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseRobert A Hauser, Ryan R Walsh, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)Robert A Hauser, Stuart Isaacson, Jerome P Lisk, et al.
Pageof 27